BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27609124)

  • 1. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
    Lee J; McKinney KQ; Pavlopoulos AJ; Han MH; Kim SH; Kim HJ; Hwang S
    Clin Chim Acta; 2016 Nov; 462():118-126. PubMed ID: 27609124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks.
    Uzawa A; Mori M; Sawai S; Masuda S; Muto M; Uchida T; Ito S; Nomura F; Kuwabara S
    Clin Chim Acta; 2013 Jun; 421():181-3. PubMed ID: 23535508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica.
    Takano R; Misu T; Takahashi T; Izumiyama M; Fujihara K; Itoyama Y
    Tohoku J Exp Med; 2008 May; 215(1):55-9. PubMed ID: 18509235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
    Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
    Misu T; Takano R; Fujihara K; Takahashi T; Sato S; Itoyama Y
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):575-7. PubMed ID: 19372295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
    Jiang S; Wu J; Yang Y; Liu J; Ding Y; Ding M
    Mol Med Rep; 2012 Nov; 6(5):1081-6. PubMed ID: 22895575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
    Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
    Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica and astrocytic damage in its pathogenesis.
    Fujihara K
    J Neurol Sci; 2011 Jul; 306(1-2):183-7. PubMed ID: 21396661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations.
    Bergamaschi R; Tonietti S; Franciotta D; Candeloro E; Tavazzi E; Piccolo G; Romani A; Cosi V
    Mult Scler; 2004 Feb; 10(1):2-4. PubMed ID: 14760945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
    Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
    Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
    Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X
    J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
    Nielsen HH; Beck HC; Kristensen LP; Burton M; Csepany T; Simo M; Dioszeghy P; Sejbaek T; Grebing M; Heegaard NH; Illes Z
    PLoS One; 2015; 10(10):e0139659. PubMed ID: 26460890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
    Kuroda H; Fujihara K; Takano R; Takai Y; Takahashi T; Misu T; Nakashima I; Sato S; Itoyama Y; Aoki M
    J Neuroimmunol; 2013 Jan; 254(1-2):178-82. PubMed ID: 23017732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.